US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...
University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...
2d
News Medical on MSNBreakthrough in next-generation polio vaccinesA more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.
Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...
Uttarakhand High Court acquitted a polio-affected man convicted of rape and ordered the state government to compensate him ...
Polio has emerged as a major challenge in Pakistan. It is not simply a challenge in the health sector, but has also become ...
2d
India Today on MSNBreakthrough in next-generation polio vaccine. It is safer and cheaperScientists have developed a vaccine using virus-like particles (VLPs), which mimic the poliovirus but do not contain any ...
The eradication of polio as a global health threat may be delayed unless U.S. funding cuts – potentially totaling hundreds of ...
Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).
Here are some of the 5,800 contracts the Trump administration formally canceled this week in a wave of terse emails.
A more affordable, lower-risk polio vaccine is on the horizon, research has found. A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results